HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial.

AbstractBACKGROUND:
New treatments for conduct disorder are sorely needed. We aimed to test the efficacy of divalproex sodium for the treatment of conduct disorder.
METHOD:
Seventy-one youths with conduct disorder according to DSM-IV criteria were enrolled in a randomized, controlled, 7-week clinical trial. Subjects were all adolescent males with at least 1 crime conviction. Subjects were randomized into high- and low-dose conditions and were openly managed by a clinical team. Subjects and independent outcome raters were blinded to condition. Clinical Global Impressions-Severity of Illness (CGI-S) and CGI-Improvement (CGI-I) ratings, Weinberger Adjustment Inventory ratings, and staff ratings of behavioral privilege were used to assess outcome.
RESULTS:
Intent-to-treat analyses showed significant associations between assignment to the high-dose condition and ratings on the CGI-S (p =.02) and CGI-I (p =.0008). Self-reported weekly impulse control was significantly better in the high-dose condition (p <.05), and association between improvement in self-restraint and treatment condition was of borderline statistical significance (p <.06). Parallel analyses comparing outcome by blood drug level achieved strengthened the results, as expected.
CONCLUSION:
This preliminary study in a most difficult population suggests a role for divalproex sodium in the treatment of conduct disorder. Divalproex sodium improved self-reported impulse control and self-restraint, variables shown to be predictive of criminal recidivism. Studies are needed of longer-term impact and side-effect profiles. This is one of few controlled psychopharmacologic studies of conduct disorder.
AuthorsHans Steiner, Maya L Petersen, Kirti Saxena, Sekou Ford, Zakee Matthews
JournalThe Journal of clinical psychiatry (J Clin Psychiatry) Vol. 64 Issue 10 Pg. 1183-91 (Oct 2003) ISSN: 0160-6689 [Print] United States
PMID14658966 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticonvulsants
  • Valproic Acid
Topics
  • Adolescent
  • Aggression (drug effects)
  • Anger (drug effects)
  • Anticonvulsants (administration & dosage, adverse effects)
  • Arousal (drug effects)
  • Conduct Disorder (diagnosis, drug therapy)
  • Crime (prevention & control)
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Humans
  • Internal-External Control
  • Juvenile Delinquency (rehabilitation)
  • Male
  • Personality Assessment
  • Personality Inventory
  • Residential Treatment
  • Socialization
  • Treatment Outcome
  • Valproic Acid (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: